US › Healthcare

Celularity Inc (CELU)

US · Healthcare · Biotechnology

$0.76+4.80%

Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Revenue

$3.8M

Revenue YoY

-32.9%

Net profit

$874,000

EPS

$0.02

Net margin

22.7%

Key statistics

Market cap

$23.5M

Forward P/E

0.0

P/B

9.89

Book value

$-1.21

EPS (TTM)

$-1.69

52-week high

$2.55

52-week low

$0.56

50-day MA

$1.32

200-day MA

$1.08

Beta

0.88

Analyst view

with an average price target of $2.50.

Shareholding

Insiders

33.27%

Institutions

11.50%

Largest institutional holders

Fund	Stake
C V Starr & Co Inc	2.35%
Vanguard Capital Management, LLC	1.91%
Geode Capital Management, LLC	0.52%
Citadel Advisors Llc	0.31%
Vanguard Fiduciary Trust Co	0.25%
BlackRock Inc	0.24%
State Street Corp	0.18%
HRT FINANCIAL LLC	0.17%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Celularity Inc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-11-07.